David R. Braxton

Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens

David R. Braxton, Cynthia Cohen, Momin T. Siddiqui · Diagnostic Cytopathology · 2014 · 53 citations

Medicine, Oncology, Pathology +16

Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma”

David R. Braxton, Debra Saxe, Nevena Damjanov et al. · Human Pathology · 2017 · 38 citations

Medicine, Oncology, Pathology +17

Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens

Shonan Sho, Colin M. Court, Stephen Kim et al. · PLoS ONE · 2017 · 32 citations · Full text

Medicine, Oncology, Pathology +17

The GCTM-5 Epitope Associated with the Mucin-Like Glycoprotein FCGBP Marks Progenitor Cells in Tissues of Endodermal Origin

Lincon A. Stamp, David R. Braxton, Jun Wu et al. · Stem Cells · 2012 · 26 citations · Full text

Life Sciences, Cell Biology, Pathology +16

Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution

David R. Braxton, Ray Zhang, Jennifer D. Morrissette et al. · International Journal of Cancer · 2016 · 19 citations · Full text

Medicine, Genetics, Oncology +17